Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting central nervous system disorders. Its structural framework supports the development of ligands for neurotransmitter receptors, including dopamine and serotonin receptors. Commonly employed in the creation of experimental drugs aimed at treating depression, anxiety, and Parkinson’s disease. Also utilized in the design of selective enzyme inhibitors due to its rigid bicyclic scaffold, which enhances binding specificity. Shows potential in medicinal chemistry for optimizing drug candidates with improved metabolic stability and blood-brain barrier penetration.